hotspot -WSS

hotspot

author：comprehensive 2025-10-01 15:00:08 - browse：27366

Illustration of a red heart. -- health coverage from STAT — Adobe

Novo Nordisk’s obesity drug Wegovy cut the risk of major heart complications by 20% in a closely watched trial, results that could streamline insurance coverage and spur even greater demand for the highly popular therapy.

The milestone Select trial of about 17,500 patients is the first to show that an obesity medication leads to long-term cardiovascular benefits. The company reported only the topline figure in a press release Tuesday, and did not break out the reductions it said were seen in heart attacks, strokes, and cardiovascular deaths — the combined components of the study’s primary outcome. It said all three contributed to the decrease in cardiovascular events in the group that received Wegovy compared with participants given a placebo.

The 20% reduction was greater than many observers were expecting. In a research note Tuesday, Jefferies analysts called the results a “best case” outcome. “If they play baseball in Denmark,” Barclays analyst Emily Field wrote in a note, “Wegovy just hit a home run.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Leqembi, other new Alzheimer’s drugs require better biomarkers

leisure time

WSS

Profiling embryos to choose those with higher IQs is almost a reality

How the political right came to back psychedelics to treat trauma

Study: Pain burden is higher in Black NFL players than white ones

Living with Fabry disease, a condition that causes chronic pain

Iowa House, Senate pass 6

Why ADHD is under

knowledge

hotspot

leisure time

Continuity nursing helped my family in our darkest PICU moments

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

New air purifier tech could be key to improving indoor air quality

Charles Manson follower Leslie Van Houten released from prison after 53 years

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Oak trusses raised to roof of fire

Anesthesiologist group: stop taking Ozempic before surgery

HCA discloses massive data breach affecting 11 million patients

Medical records are filled with copy

Gene therapy denied for Afghan refugee whose father aided U.S.

leisure time

NIH fellows want a pay raise. Will that mean less money for grants?

Male doctors called my cancer incurable. A female doctor showed it wasn't

Life science postdocs should get big pay hike, NIH panel says

Leqembi, other new Alzheimer’s drugs require better biomarkers

At JPM 2024, hospital systems pitch financial strength to investors

Charles Manson follower Leslie Van Houten released from prison after 53 years

Wikipedia

leisure time

focus

focus